financetom
Business
financetom
/
Business
/
Wayfair Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wayfair Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
Oct 28, 2025 5:06 AM

07:32 AM EDT, 10/28/2025 (MT Newswires) -- Wayfair ( W ) reported Q3 adjusted earnings Tuesday of $0.70 per diluted share, compared with $0.22 a year earlier.

Analysts surveyed by FactSet expected $0.44.

Revenue for the quarter ended Sept. 30 was $3.12 billion, compared with $2.88 billion a year earlier.

Analysts surveyed by FactSet expected $3.02 billion.

The company's shares were up 11% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boston Scientific Gets US FDA Approval for Expanded Indication of Ingevity + Pacing Leads
Boston Scientific Gets US FDA Approval for Expanded Indication of Ingevity + Pacing Leads
Sep 17, 2024
08:06 AM EDT, 09/17/2024 (MT Newswires) -- Boston Scientific ( BSX ) said Tuesday that it has received US Food and Drug Administration approval to expand the indication for Ingevity with pacing leads. Pacing leads are thin wires placed inside the heart and connected to an implantable device for the treatment of symptomatic bradycardia. This technique could decrease the long-term...
Cardinal Health to Distribute Telix Pharmaceuticals' Kidney Cancer Imaging Tool
Cardinal Health to Distribute Telix Pharmaceuticals' Kidney Cancer Imaging Tool
Sep 17, 2024
08:08 AM EDT, 09/17/2024 (MT Newswires) -- Cardinal Health ( CAH ) has been selected by Australia's Telix Pharmaceuticals as a commercial radiopharmaceutical distributor to supply Zircaix for the imaging of kidney cancer in the US, the companies said on Tuesday. Financial terms weren't disclosed. The distribution agreement is subject to regulatory approval, according to the companies. Price: 114.60, Change:...
Stellantis working hard to avoid Volkswagen plant closure scenario, CEO says
Stellantis working hard to avoid Volkswagen plant closure scenario, CEO says
Sep 17, 2024
TURIN (Reuters) - Stellantis ( STLA ) has already taken measures and is working hard to avoid the risk of plant closures facing rival Volkswagen, the carmaker's CEO Carlos Tavares said on Tuesday. We have done many unpopular things over the last few years to avoid as much as possible a situation similar to Volkswagen, Tavares said. We have been...
Cigna's Express Scripts Seeks Retraction of July 2024 Drug Pricing Report in Lawsuit Against FTC
Cigna's Express Scripts Seeks Retraction of July 2024 Drug Pricing Report in Lawsuit Against FTC
Sep 17, 2024
08:05 AM EDT, 09/17/2024 (MT Newswires) -- Cigna Group ( CI ) said Tuesday its Express Scripts by Evernorth unit has sued the Federal Trade Commission in Missouri federal court, demanding the retraction of the regulator's July 2024 drug pricing report on the pharmacy benefit management, or PBM industry. Cigna ( CI ) said the July 2024 report makes unsubstantiated,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved